Veterinary Medicine Ceftiofur Sodium for Injection for Animal

• Customization: Available
• Varieties: Infectious Disease Prevention Medicine
• Component: Chemical Synthetic Drugs
• Model NO.: Ceftiofur Sodium for Injection
• Type: The First Class
• Pharmacodynamic Influential Factors: Animal Species
• Storage Method: Light Proof
• Veterinary Reg. No.: 220042021
• Main Ingredient: Ceftiofur Sodium
• Character: White to Light Yellow Powder or Sparse Block
• Usage: Injection
• Expiry Date: 2 Years
• GMP: 22018
• Transport Package: Box
• Specification: 4g/vial
• Trademark: SINDER
• Origin: Sichuan, China
• HS Code: 3004209099
• Production Capacity: 100000L/Year
• Package Size: 45.00cm * 31.00cm * 23.00cm
• Package Gross Weight: 9.300kg

Product Description

Instruction of Ceftiofur Sodium for Injection

Prescription drug for veterinary use
[Product name] Generic name: Ceftiofur Sodium for Injection
[Main ingredient] Ceftiofur Sodium
[Character] White to light yellow powder or sparse block.
[pharmacological action]
(1)Pharmacodynamics
Ceftiofur is a kind of β-lactam antibacterials, this product has broad-spectrum antibacterial action which is effective for gram positive bacteria and gram negative bacteria (including bacteria producing β-lactamase). The antibacterial mechanism is inhibition of bacterial cell wall synthesis and lead to bacterial death. The sensitive bacteria include Pasteurella multocida, hemolytic Pasteurella, Actinobacillus pleuropneumoniae, Salmonella, E. coli, Streptococcus, Staphylococcus aureus, some of Pseudomonas aeruginosa and enterococci are resistant. This product has strong antibacterial activity than ampicillin and stronger activity against streptococci than fluoroquinolones.
(2)Pharmacokinetics
This product can not be absorbed by oral administration, but can be absorbed rapidly by intramuscular injection and subcutaneous injection, it can spread widely but can not pass through the blood-brain barrier. The drug concentration is high in the blood and organization, and the effective drug concentration can last a very long period. The active metabolin (deoxidizing furoyl cefriofur) is formed in vivo and it can be metabolized to un-active product excreted from urine and faeces in further. The drug concentration in the blood can be improved and half-life period can be lengthened when administrated together with drugs which inhibiting excretion.
[Drug Interactions]There is synergistic effect when this drug is administrated together with penicillin and aminoglycoside drugs.
[Indication]It is used to cure chicks infection caused by E.coli.
[Usage and dosage] Subcutaneous injection: for 1-day-old chicks, 0.1-0.2mg each.
[Adverse reactions](1) May cause gastrointestinal flora disorder or superinfection. (2) May cause certain renal toxicity.
[Precaution]Mix with diluent when use.
[Withdrawal time] 0 day for chicks.
[Specification] 1.0g, 4.0g calculated by C₁₉H₁₇N₅O₇S₃.
[Package] 1.0g or 4.0g /vials*20 vials/ctn. 
[Storage] sealed, cool, away from sunshine.
[Expiry date] 2 years.
Approval No.: Veterinary drug (2012)220042021
Executive Standard: <Chinese Veterinary Pharmacopoeia>, 2010 version, 1^st section.
Producing License No.: (2015) Veterinary drug 22004.
Veterinary GMP Approval No.: (2015) Veterinary drug GMP No.22018.
Address: Zitong Economic zone, Mianyang, Sichuan Province, China.
 

Shandong Sinder Technology Co., Ltd ('Sinder') founded in April 1999, has a wide range of animal health products. Sinder focus on Animal Health Products, Animal Vaccine, Antibodies, Antibiotics, Feed Additives, Chinese Herbal Product, Pet food, Elisa, and PCR test kit.

Sinder always persists in the core concept of 'The Relentless Pursuit of Increasing Customer Value. ' Based on the animal health to achieve a service provider for ecological construction of agriculture and animal husbandry. Support the efficient and sustainable development of agriculture and animal husbandry. Make food safer and rural areas better!

Sinder is a high-tech enterprise and one of the top 10 veterinary drug manufacturers in China and focusing on the animal health business. At the moment, the company has 35 GMP production lines, 1 CNAS laboratory, 3 national scientific research platforms, and 8 provincial scientific research platforms owned by Sinder.

Sinder has 4 R&D centers located in Qingdao, Zhucheng, and Beijing, China, and 1 laboratory in Silicon Valley in the United States. At present, the company has 1,535 employees including more than 200 masters or above and 18 doctors. Also, the company established extensive technical cooperation with several domestic and foreign scientific research institutes, animal health companies, and domestic veterinary medicine enterprises. Sinder has undertaken 57 national, provincial, and ministerial projects, gained 7 provincial and ministerial science and technology progress awards, presided over or participated in 23 national standards, obtained 23 new veterinary drug certificates(one 1st class new drug), and 60 authorized patents.